Skip to content

Author

Mohammad Abohassan

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Nov 2026

Engineering dual-targeted lipid nanocarriers for precision delivery of quercetin in breast cancer therapy: a comprehensive review.

A significantly higher mortality rate in breast cancer than in lung cancer worldwide raises serious concerns despite advances in biomarker research and diagnosis. Conventional chemotherapeutics are usually associated with poor tumor selectivity, multi-drug resistance, adverse effects due to the conventional route of ad...

Ashadul Hoque, Shubhrajit Mantry, A. Bhunia et al. · 0 citations
Open access Nov 2026

Inflammatory biomarker profiles and their associations with Nordic dietary habits and metabolic outcomes in adults affected by MAFLD

Metabolic dysfunction-associated fatty liver disease (MAFLD) is commonly accompanied by chronic low-grade inflammation. The Aggregate Index of Systemic Inflammation (AISI) is an accessible inflammatory marker, while the Healthy Nordic diet may have favorable metabolic effects. This study investigated relationships amon...

Amr A. El-Sehrawy, Ismail Kandil, G. Elmazny et al. · 0 citations
Open access Oct 2026

Neutrophil-to-lymphocyte ratio (NLR) in relation to metabolic profile and dietary antioxidant quality in adults with non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is a common metabolic condition characterized by hepatic steatosis and chronic low-grade inflammation, with oxidative stress playing a pivotal role in its progression. The neutrophil-to-lymphocyte ratio (NLR) has been proposed as an accessible marker reflecting systemic inflamm...

Amr A. El-Sehrawy, Ahmed M. Salah, Ismail Kandil et al. · 0 citations
Open access Sep 2026

Association of the cardiometabolic index with hepatic enzymes and metabolic profiles among adults with overweight and obesity

Growing evidence suggests that composite metabolic indices may offer valuable insights into obesity-related complications. The Cardiometabolic Index (CMI), a surrogate marker of adverse lipid profiles and central adiposity, has emerged as a promising indicator of cardiometabolic risk. Nevertheless, its association with...

Amr A. El-Sehrawy, Ismail Kandil, M. Maashi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.